APP-FUBINACA is a synthetic cannabinoid based on indazole that has been marketed as a designer drug online. Pharmacological testing indicated that APP-FUBINACA had only moderate affinity with a Ki of 708 nM for the CB1 receptor, while its EC50 was not tested. It retains in its structure a trace of the phenylalanine amino acid.